$824.38 Million in Sales Expected for Teradyne, Inc. (NYSE:TER) This Quarter

Equities research analysts expect Teradyne, Inc. (NYSE:TERGet Rating) to post $824.38 million in sales for the current quarter, according to Zacks. Six analysts have made estimates for Teradyne’s earnings. The highest sales estimate is $832.00 million and the lowest is $814.30 million. Teradyne reported sales of $1.09 billion in the same quarter last year, which indicates a negative year-over-year growth rate of 24.4%. The company is expected to issue its next quarterly earnings results on Monday, January 1st.

On average, analysts expect that Teradyne will report full-year sales of $3.43 billion for the current financial year, with estimates ranging from $3.33 billion to $3.51 billion. For the next year, analysts expect that the firm will report sales of $4.18 billion, with estimates ranging from $4.03 billion to $4.40 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that that provide coverage for Teradyne.

Separately, StockNews.com assumed coverage on Teradyne in a research note on Thursday, March 31st. They issued a “hold” rating on the stock.

TER stock opened at $101.86 on Friday. Teradyne has a fifty-two week low of $98.64 and a fifty-two week high of $168.91.

Teradyne Company Profile (Get Rating)

Teradyne, Inc designs, develops, manufactures, sells, and supports automatic test equipment worldwide. The company operates through Semiconductor Test, System Test, Industrial Automation, and Wireless Test segments. The Semiconductor Test segment offers products and services for wafer level and device package testing in automotive, industrial, communications, consumer, smartphones, cloud computer and electronic game, and other applications.

Featured Articles

Get a free copy of the Zacks research report on Teradyne (TER)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.